by Madaline Spencer | Jan 15, 2025
Andrés Klein, PhD, Associate Professor and Director of the Doctorate Program in Sciences and Innovation in Medicine at Universidad del Desarrollo, Santiago, Chile, discusses the identification of genetic modifiers for treatment in lysosomal disorders. ...
by Madaline Spencer | Jan 14, 2025
Madelyn Schloss, Social Media and Development Associate for Gaucher Community Alliance, discusses the organization. The Gaucher Community Alliance is a non-profit organization run by patients with Gaucher disease, offering advocacy, education, patient...
by Madaline Spencer | Jan 13, 2025
Juozas Gordevicius, PhD, Chief Technology Officer of VUGENE Vilnius, Lithuania, discusses autophagy-lysosomal systems in Parkinson’s disease. Parkinson’s disease is a neurological disorder causing unintended or uncontrollable movements, such as shaking,...
by Madaline Spencer | Jan 12, 2025
Hypoparathyroidism is a rare endocrine disorder characterized by a deficiency of parathyroid hormone (PTH), which leads to decreased serum calcium and increased phosphorus levels in the blood. Etiology The most common cause of hypoparathyroidism is unintended...
by Madaline Spencer | Jan 10, 2025
Gregory Grabowski, MD, discusses the use of whole genome sequencing and artificial intelligence (AI) in epigenetics and epigenomics. Epigenetics and epigenomics provide critical insights into why family members with the same disease may exhibit distinct...
